Improved Voriconazole Topical Delivery by Nanoparticles (Minireview)
- Авторлар: Nassiri-Kashani M.1, Namdar R.2,3, Nafisi S.2,3, Maibach H.I.3
- 
							Мекемелер: 
							- Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences
- Department of Chemistry, Central Tehran Branch
- Department of Dermatology, University of California
 
- Шығарылым: Том 50, № 2 (2016)
- Беттер: 76-79
- Бөлім: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244322
- DOI: https://doi.org/10.1007/s11094-016-1401-6
- ID: 244322
Дәйексөз келтіру
Аннотация
Voriconazole is a triazole antifungal drug used to treat invasive fungal infections including candidiasis, aspergillosis, and certain emerging fungal infections. Voriconazole demonstrates low water solubility. Therefore, drug solubilization is necessary for effective topical delivery. Nano-strategy may overcome its poor aqueous solubility as well as controlled drug release at action site, reduction of total dose, avoidance of systemic absorption and dosage form retention on skin. In topical antifungal administration, drug should pass outermost layer of skin; stratum corneum to reach lower layers, particularly into follicular epithelium. Nano-formulations including colloidal systems, vesicular carriers, and nanoparticles may play a major role for enhancing antifungals permeation profile. Present review surveys key experiments with voriconazole nano-based formulations used in superficial fungal infections treatment.
Негізгі сөздер
Авторлар туралы
Mansour Nassiri-Kashani
Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences
														Email: maibachh@derm.ucsf.edu
				                					                																			                												                	Иран, 							Tehran						
Roshanak Namdar
Department of Chemistry, Central Tehran Branch; Department of Dermatology, University of California
														Email: maibachh@derm.ucsf.edu
				                					                																			                												                	Иран, 							Tehran, IAU; San Francisco, CA						
Shohreh Nafisi
Department of Chemistry, Central Tehran Branch; Department of Dermatology, University of California
							Хат алмасуға жауапты Автор.
							Email: drshnafisi@gmail.com
				                					                																			                												                	Иран, 							Tehran, IAU; San Francisco, CA						
Howard Maibach
Department of Dermatology, University of California
							Хат алмасуға жауапты Автор.
							Email: maibachh@derm.ucsf.edu
				                					                																			                												                	АҚШ, 							San Francisco, CA						
Қосымша файлдар
 
				
			 
						 
						 
						 
					 
						 
									 
  
  
  
  
  Мақаланы E-mail арқылы жіберу
			Мақаланы E-mail арқылы жіберу  Ашық рұқсат
		                                Ашық рұқсат Рұқсат берілді
						Рұқсат берілді Тек жазылушылар үшін
		                                		                                        Тек жазылушылар үшін
		                                					